ETF PROAI

FMEDvsIDEV

Fidelity Covington Trust - Disruptive Medicine ETF against iShares Core MSCI International Developed Markets ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
FMED 128IDEV 111Oct 25Sep 26GROWTH OF $100
Head to head
FMEDIDEV
Expense ratio0.50%0.040%
Assets$55M$32.2B
Net flow, 1 month—+$892M
Net flow, 1 year—+$7.3B
Return, YTD+19.7%+8.6%
Return, 1 year+27.7%+10.9%
Avg daily volume7K1.9M
Holdings632281
ListedJun 12, 2023Mar 21, 2017
Options marketYesYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.